Cargando…

Analytical Validation of a Pan-Cancer Panel for Cell-Free Assay for the Detection of EGFR Mutations

Liquid biopsies have increasingly shown clinical utility. Although next-generation sequencing has been widely used for the detection of somatic mutations from plasma, performance characteristics vary by platform. Therefore, thorough validation is mandatory for clinical use. This study aimed to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	So, Min-Kyung, Park, Jong-Ho, Kim, Jong-Won, Jang, Ja-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227964/ https://www.ncbi.nlm.nih.gov/pubmed/34199654 http://dx.doi.org/10.3390/diagnostics11061022

Ejemplares similares

Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations
por: Cho, Yong Gon, et al.
Publicado: (2023)

Clinical Utility of Plasma Cell-Free DNA EGFR Mutation Analysis in Treatment-Naïve Stage IV Non-Small Cell Lung Cancer Patients
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
por: Kim, Hye-Ryoun, et al.
Publicado: (2013)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

Analytical validation and implementation of a pan cancer next-generation sequencing panel, CANSeq(TM)Kids for molecular profiling of childhood malignancies
por: Schilter, Kala F., et al.
Publicado: (2023)

Development and Analytical Validation of a Targeted Next-Generation Sequencing Panel to Detect Actionable Mutations for Targeted Therapy
por: Wang, Dandan, et al.
Publicado: (2021)

Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
por: Li, Yuping, et al.
Publicado: (2017)

Validation of an NGS mutation detection panel for melanoma
por: Reiman, Anne, et al.
Publicado: (2017)

Correction: Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
Publicado: (2017)

A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood
por: Selvarajah, Shamini, et al.
Publicado: (2021)

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance
por: Schwartzberg, Lee S., et al.
Publicado: (2020)

Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera
por: Holbrook, Myndi G., et al.
Publicado: (2021)

Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay
por: Guo, Qiao-mei, et al.
Publicado: (2019)

Validation of Customized Cancer Panel for Detecting Somatic Mutations and Copy Number Alterations
por: Choi, Su-Hye, et al.
Publicado: (2017)

Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients
por: Vollbrecht, Claudia, et al.
Publicado: (2018)

Analytical and clinical concordance of free light chain assay
por: Smith, Andrew, et al.
Publicado: (2018)

SAT630 Analytical Validation Of A Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay
por: Iyer, Priyanka, et al.
Publicado: (2023)

Detection of somatic variants and EGFR mutations in cell-free DNA from non-small cell lung cancer patients by ultra-deep sequencing using the ion ampliseq cancer hotspot panel and droplet digital polymerase chain reaction
por: Sung, Jae Sook, et al.
Publicado: (2017)

Effects of Different Centrifugation Protocols on the Detection of EGFR Mutations in Plasma Cell-Free DNA
por: Shin, Kyung-Hwa, et al.
Publicado: (2022)

EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
por: Kim, Minhye, et al.
Publicado: (2021)

Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers
por: Gilson, Pauline, et al.
Publicado: (2021)

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
por: Lanman, Richard B., et al.
Publicado: (2015)

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies
por: Jensen, Steffen Grann, et al.
Publicado: (2021)

The analytical validation of the Oncotype DX Recurrence Score assay
por: Baehner, Frederick L
Publicado: (2016)

Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations
por: Poole, Jason C., et al.
Publicado: (2019)

A Panel of High Resolution Melting (HRM) Technology-Based Assays with Direct Sequencing Possibility for Effective Mutation Screening of EGFR and K-ras Genes
por: Heideman, D. A. M., et al.
Publicado: (2009)

ESR1 NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of ESR1 Mutations in Liquid Biopsies
por: Stergiopoulou, Dimitra, et al.
Publicado: (2021)

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
por: Park, Song Ee, et al.
Publicado: (2019)

A Comparative Study for Detection of EGFR Mutations in Plasma Cell-Free DNA in Korean Clinical Diagnostic Laboratories
por: Kim, Yoonjung, et al.
Publicado: (2018)

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
por: Jung, Hyun Ae, et al.
Publicado: (2020)

Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment
por: Kunwar, Arzu, et al.
Publicado: (2023)

Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display
por: Kunamneni, Adinarayana, et al.
Publicado: (2019)

Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients
por: Altuğ, Yücel, et al.
Publicado: (2019)

Predicting EGFR Mutation in Lung Adenocarcinoma: Development and Validation of the EGFR Mutation Predictive Score (EMPS) in Bali, Indonesia
por: Njoto, Edwin Nugroho, et al.
Publicado: (2023)

Construction of a reference material panel for detecting KRAS/NRAS/EGFR/BRAF/MET mutations in plasma ctDNA
por: Xu, Jun, et al.
Publicado: (2021)

Detection of EGFR Mutations by TaqMan Mutation Detection Assays Powered by Competitive Allele-Specific TaqMan PCR Technology
por: Roma, Cristin, et al.
Publicado: (2013)

Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
por: Hoshi, Hirotaka, et al.
Publicado: (2017)

Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
por: Lee, Ji Yun, et al.
Publicado: (2016)

PanSNPdb: The Pan-Asian SNP Genotyping Database
por: Ngamphiw, Chumpol, et al.
Publicado: (2011)

Analytical Validation of Two Assays for Equine Ceruloplasmin Ferroxidase Activity Assessment
por: Cecchini Gualandi, Stefano, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mdk26dgd1umn1i92griemd6q9t